PIK3CA amplification was detected in 5 PIK3CA mutant samples (14.7%, 5/34) which was more prevalent in lung squamous cell carcinoma (4/12 for lung squamous cell carcinoma vs. 1/12 for lung adenocarcinomas, p = 0.042). This evidence concerns the gene PIK3CA and lung adenocarcinoma.